Safeguarding America’s Pharmaceutical Supply Chain

Guest Contributor AMAC May 5, 2025
Safeguarding America’s Pharmaceutical Supply Chain
Myriam Zilles
Trump’s Section 232 review aims to secure the pharmaceutical supply chain, reduce China dependency, and strengthen U.S. healthcare resilience.


Comment
Show comments Hide Comments


Related Articles

Copyright © RealClearHealth, LLC
© RealClearHealth | | Go to full site